SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-016481
Filing Date
2021-12-02
Accepted
2021-12-02 16:36:04
Documents
14
Period of Report
2021-12-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K enfn-20211202x8k.htm   iXBRL 8-K 39255
2 EX-99.1 enfn-20211202xex99d1.htm EX-99.1 198691
3 GRAPHIC enfn-20211202xex99d1001.jpg GRAPHIC 2147
  Complete submission text file 0001558370-21-016481.txt   378168

Data Files

Seq Description Document Type Size
4 EX-101.SCH enfn-20211202.xsd EX-101.SCH 3037
5 EX-101.LAB enfn-20211202_lab.xml EX-101.LAB 16584
6 EX-101.PRE enfn-20211202_pre.xml EX-101.PRE 10717
7 EXTRACTED XBRL INSTANCE DOCUMENT enfn-20211202x8k_htm.xml XML 5062
Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Filer) CIK: 0001868912 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40949 | Film No.: 211467115
SIC: 7372 Services-Prepackaged Software